|
業務類別
|
-- |
|
業務概覽
|
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability todeliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies thatcan provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays. |
| 公司地址
| 200 Arsenal Yards Boulevard, Suite 210, Watertown, MA, USA, 02472 |
| 電話號碼
| +1 617 758-8672 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.sqzbiotech.com |
| 員工數量
| 53 |
| Mr. David First |
Chief People Officer |
-- |
26/04/2023 |
| Dr. Howard Bernstein, M.D.,PhD |
Director and Interim Chief Executive Officer |
-- |
26/04/2023 |
| Mr. Lawrence J. Knopf |
General Counsel |
-- |
26/04/2023 |
| Ms. Marshelle Smith Warren, M.D. |
Chief Medical Officer |
-- |
26/04/2023 |
| Mr. Richard Capasso |
Principal Financial Officer and Chief Accounting Officer |
-- |
26/04/2023 |
|
|
| Dr. Sapna Srivastava, PhD |
Independent Director |
26/04/2023 |
| Dr. Paul B. Bolno, M.D. |
Independent Director |
26/04/2023 |
| Dr. Marc Schegerin, M.D. |
Independent Director |
26/04/2023 |
| Dr. Howard Bernstein, M.D.,PhD |
Director and Interim Chief Executive Officer |
26/04/2023 |
| Dr. Klavs F. Jensen, PhD |
Independent Director |
26/04/2023 |
| Mr. Marc Elia |
Independent Director |
26/04/2023 |
| Dr. Pushkal Garg, M.D. |
Independent Director |
26/04/2023 |
| Dr. Bernard Coulie, M.B.A.,M.D.,PhD |
Chairman of the Board |
26/04/2023 |
| Ms. Amy W. Schulman |
Director |
26/04/2023 |
| Dr. Patrick V.J.J. Vink, M.D. |
Independent Director |
26/04/2023 |
|
|
|
|
